AOD-9604 vs MOTS-c vs Tesamorelin | Research Guide

AOD-9604 vs MOTS-c vs Tesamorelin | Research Guide Compare AOD-9604 vs MOTS-c vs Tesamorelin research mechanisms, differences, and how they're studied together. Research use only. AOD-9604 vs MOTS-c vs Tesamorelin | Research Guide AOD-9604, MOTS-c, and Tesamorelin are three distinct research peptides studied for different mechanistic pathways AOD-9604 is investigated for its fragment-based relationship to lipid metabolism research, MOTS-c is a mitochondrial-derived peptide studied in the context of metabolic and cellular energy research, and Tesamorelin is a GHRH analog studied for its influence on the growth hormone axis. While these three compounds are frequently searched together, they don’t share a single mechanism each interacts with a different biological pathway, which is precisely why researchers often examine them side by side rather than as interchangeable options. This distinction matters because peptide research literature groups these three under related but non-identical categories. A 2023 review in Frontiers in Physiology noted that mitochondrial-derived peptides like MOTS-c represent a functionally separate class from growth-hormone-axis compounds such as Tesamorelin underscoring why comparison, rather than substitution, is the right framework for evaluating them. For a broader primer on how researchers approach compound selection generally, see our complete peptide research guide. This guide breaks down what AOD-9604 vs MOTS-c vs Tesamorelin is studied for, how their mechanisms diverge, and what current research indicates about examining them in combined study designs including where a fourth compound, Ipamorelin, fits into that picture. What Is AOD-9604? AOD-9604 is a modified fragment of the human growth hormone (hGH) molecule, specifically corresponding to amino acids 176–191 of the hGH sequence, and is studied in research settings for its relationship to lipid metabolism. Unlike full-length growth hormone, AOD-9604 was developed to isolate the fragment associated with fat-metabolizing activity while excluding the region linked to growth-promoting effects. This distinction has made it a recurring subject in metabolic peptide research. Mechanism of Action in Research Models AOD-9604 is researched for its involvement in lipolysis pathways, the process of breaking down stored fat for energy.Because it retains only the C-terminal fragment of the hGH molecule, researchers use it to isolate this specific activity from the broader hormonal cascade triggered by full hGH, allowing for more targeted study of fat-metabolism mechanisms without the confounding variables introduced by growth-hormone-axis activation. This fragment-based approach is what differentiates AOD-9604 from GHRH analogs such as Tesamorelin, which act upstream in the pituitary rather than directly on metabolic pathways. Primary Research Applications AOD-9604 is most commonly referenced in published research on obesity and metabolic studies, cellular fat-regulation models, and comparative peptide-fragment research examining structure-activity relationships within the hGH sequence. Its narrow, fragment-specific mechanism makes it a frequent compa